[go: up one dir, main page]

FR3068238B1 - THREE-PHASE COMPOSITION - Google Patents

THREE-PHASE COMPOSITION Download PDF

Info

Publication number
FR3068238B1
FR3068238B1 FR1756206A FR1756206A FR3068238B1 FR 3068238 B1 FR3068238 B1 FR 3068238B1 FR 1756206 A FR1756206 A FR 1756206A FR 1756206 A FR1756206 A FR 1756206A FR 3068238 B1 FR3068238 B1 FR 3068238B1
Authority
FR
France
Prior art keywords
phase
phase composition
distinct
phases
density
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1756206A
Other languages
French (fr)
Other versions
FR3068238A1 (en
Inventor
Helene Balbusquier
Julie Nizan
Julie Cani
Elodie Galandrin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Capsum SAS
Original Assignee
Capsum SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capsum SAS filed Critical Capsum SAS
Priority to FR1756206A priority Critical patent/FR3068238B1/en
Priority to PCT/EP2018/067649 priority patent/WO2019002579A1/en
Publication of FR3068238A1 publication Critical patent/FR3068238A1/en
Application granted granted Critical
Publication of FR3068238B1 publication Critical patent/FR3068238B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/03Liquid compositions with two or more distinct layers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)

Abstract

La présente invention concerne une composition comprenant au moins une première phase (F1) et une deuxième phase (F2) distinctes, non miscibles entre elles à température ambiante et à pression atmosphérique, et comprenant en outre au moins une troisième phase (F3) à l'interface des phases (F1) et (F2), dans laquelle : - la densité de la phase (F2) est supérieure à la densité de la phase (F1), - la phase (F3) comprend des particules (P) de taille supérieure à 50 µm, et - les phases (F1), (F2) et (F3) sont distinctes au repos.The present invention relates to a composition comprising at least a first phase (F1) and a second phase (F2) which are distinct, immiscible with one another at room temperature and at atmospheric pressure, and further comprising at least a third phase (F3) at '' interface of phases (F1) and (F2), in which: - the density of phase (F2) is greater than the density of phase (F1), - phase (F3) comprises particles (P) of size greater than 50 µm, and - phases (F1), (F2) and (F3) are distinct at rest.

FR1756206A 2017-06-30 2017-06-30 THREE-PHASE COMPOSITION Expired - Fee Related FR3068238B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1756206A FR3068238B1 (en) 2017-06-30 2017-06-30 THREE-PHASE COMPOSITION
PCT/EP2018/067649 WO2019002579A1 (en) 2017-06-30 2018-06-29 Three-phase composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1756206 2017-06-30
FR1756206A FR3068238B1 (en) 2017-06-30 2017-06-30 THREE-PHASE COMPOSITION

Publications (2)

Publication Number Publication Date
FR3068238A1 FR3068238A1 (en) 2019-01-04
FR3068238B1 true FR3068238B1 (en) 2020-07-31

Family

ID=59811586

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1756206A Expired - Fee Related FR3068238B1 (en) 2017-06-30 2017-06-30 THREE-PHASE COMPOSITION

Country Status (2)

Country Link
FR (1) FR3068238B1 (en)
WO (1) WO2019002579A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7359360B2 (en) * 2018-12-19 2023-10-11 エルブイエムエイチ レシェルシェ Redispersible three-layer cosmetic
JP7276784B2 (en) * 2018-12-19 2023-05-18 エルブイエムエイチ レシェルシェ Redispersible two-layer cosmetic
FR3103706B1 (en) 2019-12-03 2023-05-19 Laboratoires M&L Three-phase cosmetic composition
KR102607454B1 (en) * 2020-12-18 2023-11-29 코스맥스파마 주식회사 Pharmaceutically stable soft capsules comprising more than two different types of compositions
AU2022304712A1 (en) * 2021-06-28 2023-12-21 Lonza Greenwood Llc Liquid filled capsule with two phase liquid fill

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920883A (en) * 1972-11-15 1975-11-18 Shiseido Co Ltd Liquid cosmetic composition of a two-phase type
FR2638636B1 (en) 1988-11-09 1992-09-11 Oreal CLEANER FOR EYES WITH TWO SEPARATE PHASES
JP2796990B2 (en) 1989-05-10 1998-09-10 株式会社資生堂 Skin cosmetics
FR2699404B1 (en) 1992-12-18 1995-01-27 Oreal Two-phase cosmetic or dermatological composition for removing make-up, cleansing or caring for the skin containing benzalkonium chloride.
FR2795632A1 (en) 1999-06-30 2001-01-05 Oreal MULTI-PHASE COSMETIC COMPOSITION BASED ON A VOLATILE FLUORINATED OIL AND ITS USE FOR MAKE-UP REMOVAL AND BODY CARE
US20070167338A1 (en) * 2006-01-09 2007-07-19 Mchugh Colin M Multiphase personal care compositions comprising beads
FR2939012B1 (en) 2008-12-01 2015-03-27 Capsum PROCESS FOR MANUFACTURING A SERIES OF CAPSULES, AND ASSOCIATED SERIES OF CAPSULES
FR2954104B1 (en) 2009-12-18 2012-03-09 Oreal W / O EMULSION COMPRISING EMULSIFYING SILICONE ELASTOMER AND VOLATILE LINEAR ALKANE
FR2969907B1 (en) 2010-12-31 2014-03-07 Capsum SERIES OF CAPSULES COMPRISING AT LEAST ONE INTERNAL PHASE DROP IN AN INTERMEDIATE PHASE DROP AND METHOD OF MANUFACTURING THE SAME
FR2972371B1 (en) 2011-03-08 2013-03-15 Capsum METHOD OF FORMING DROPS FROM A FIRST PHASE DISPERSED IN A SECOND PHASE SUBSTANTIALLY IMMISCIBLE WITH THE FIRST PHASE
WO2013034366A2 (en) * 2011-09-06 2013-03-14 Unilever Plc Composition
US9387446B2 (en) * 2011-09-22 2016-07-12 Ariel-University Research And Development Company Ltd. Emulsions and methods of making emulsions
FR2983068B1 (en) * 2011-11-25 2014-01-03 Oreal TRANSPARENT COMPOSITION OF PICKERING EMULSION TYPE BASED ON AEROGEL HYDROPHOBIC PARTICLES
FR2986165B1 (en) * 2012-01-31 2015-07-24 Capsum PROCESS FOR PREPARING RIGIDIFIED CAPSULES
US9603783B2 (en) * 2013-03-26 2017-03-28 L'oreal Three-phase cosmetic compositions comprising nacres
FR3008312B1 (en) * 2013-07-12 2015-09-04 Oreal THREE-PHASE COSMETIC COMPOSITIONS COMPRISING ENCAPSULATED PIGMENTS
FR3013233B1 (en) 2013-11-19 2016-01-01 Capsum PROCESS FOR PREPARING CAPSULES COMPRISING A LIQUID CORE AND EXTERNAL SHELL
FR3041251B1 (en) 2015-09-18 2019-01-25 Capsum COMPOSITIONS IN THE FORM OF OIL-IN-WATER EMULSIONS WHOSE FATTY PHASE IS IN THE FORM OF DROPS
FR3041252B1 (en) 2015-09-18 2019-01-25 Capsum STABLE DISPERSIONS OF DROPS COMPRISING A GELIFYING AGENT

Also Published As

Publication number Publication date
WO2019002579A1 (en) 2019-01-03
FR3068238A1 (en) 2019-01-04

Similar Documents

Publication Publication Date Title
FR3068238B1 (en) THREE-PHASE COMPOSITION
Kroeze et al. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa
Batty et al. Generalizability of occupational cohort study findings
Hocqueloux et al. Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
Blom et al. Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector-to a memory-type response
Prezzemolo et al. Functional signatures of human CD4 and CD8 T cell responses to Mycobacterium tuberculosis
Rodger et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population
Canary et al. Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus–infected pigtail macaques
MA46990B1 (en) GLP-1 COMPOSITIONS AND ITS USES
Kruh-Garcia et al. Antigen 85 variation across lineages of Mycobacterium tuberculosis—Implications for vaccine and biomarker success
MA46548B1 (en) Fsh for the treatment of infertility
JP2008503539A5 (en)
Olsson et al. Kynurenine/tryptophan ratio for detection of active tuberculosis in adults with HIV prior to antiretroviral therapy
Vieillard et al. Specific anti-gp41 antibodies predict HIV-1 disease progression
Maheswaran et al. Keratin metaplasia in the epithelial lining of odontogenic cysts
Lanjewar et al. Pathology of thyroid in acquired immunodeficiency syndrome
Petrova et al. The polyclonal CD8 T cell response to influenza M158–66 generates a fully connected network of cross-reactive clonotypes to structurally related peptides: a paradigm for memory repertoire coverage of novel epitopes or escape mutants
Al Salmi et al. Epidemiology of human leukocyte antigens among omani population
Úbeda et al. Cryptococcal meningoencephalitis. Epidemiology and mortality risk factors in pre-and post-HAART era
Ricotta et al. Design of a suitable cleaning procedure for the tarnished silver elements of the reliquary bust of Santa Vittoria, Diocesan Museum of Agrigento, Sicily
FR3067490B1 (en) PROCESSING MULTISTANDARD MESSAGES
Amiard et al. Travail posté: quel (s) critère (s) de pénibilité?
Freercks et al. Haemolytic anaemia associated with efavirenz
Ruiz Pérez et al. Transcultural validation of an emotional climate scale for prison environments
Kruh-Garcia et al. Antigen 85 variation across lineages of

Legal Events

Date Code Title Description
PLSC Publication of the preliminary search report

Effective date: 20190104

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

ST Notification of lapse

Effective date: 20240205